Deramiocel BLA for Duchenne muscular dystrophy under U.S. FDA review with PDUFA target action date of August 22, 2026Pivotal ...
Expanded portfolio integrates agent development, governance, decision intelligence and domain workflows to help enterprises scale AI responsibly and deliver measurable business outcomesNEW YORK, March ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results